NSF just moved to ban almost all collaborations with Chinese scientists for its funded researchers. It will send further intimidating signals to all academic collaboration and exchange with China, not just NSF-funded work. Contrast with Cold War: the US maintained structured scientific exchanges with the USSR via academy programs & bilateral agreements, even amid deep tensions, which enabled limited but real cooperation in non-sensitive fields. https://t.co/NjYW1VbrnW
I feel like it’s harder to read articles these days. Like when paywalls first started it was hard, then it got easier, now it’s hard again. I feel like I spend half my life logging into things.
Please read this story of a dad trying to develop a drug to save his child.@Jasonmmast and I think it is one of our best.
As we were working on it, we kept coming back to the same question: If this guy can't develop a drug for a rare disease, who can?
Matt Wilsey did not sit in the lab. He did not inject the rats or slice open their brains. But he had hired the scientists who did. He recruited advisers, including Nobel Prize winners, brought together the families of other children diagnosed with the condition, and pulled together an A-team of investors and donors. Through it all, he was sustained by his devout Catholic faith.
“We carry the hopes of many,” he wrote to his staff once. “I receive emails, calls, and texts from professionals and other advocates. They are blown away by what we have accomplished and hope we are an ice breaker for them. Our trial has the potential to really boost / save a decimated field.”
Now it may run aground.
🎙️🇨🇳The China Biotech Debate: Aug. 6 in Boston🇺🇸📣
Excited to share that we'll be hosting our first (of at least two) debate and discuss events about the rise of China biotech, what it means for the patients, companies + investors across the🌎!
More details in coming days...
This whistleblower took on a health insurance giant and a political machine. She’s not stopping there. How health care radicalized Chris Deacon. https://t.co/tkznBtsNPf
@ArmstrongDrew How are the other buildings they’ve acquired doing? Because if they’ve got delayed openings or closed to the public then we’ve got a real Rule of 3 thing going…
@steveschale Adjacent, but it has long been a big missed opportunity that the @WashWizards have not been branding their home court as the “Supreme Court” this whole time.
WA state now leads GDP growth nationally, with GDP growth of 4.5% compared to 2.1% nationally. Combined with national and international fawning praise from the World Cup, Seattle/WA Doomers are having their worst week ever.
Fabulous from @salonium on what COVID vaccine was so fast. Developed in a weekend in multiple cases, 2 months of preclinical, then testing. Testing much faster than normal. Some COVID specific (500k trial volunteers just in US, high infection rate = quick learning), some not. 1/2
At the start of the World Cup, I began trying to see if each day I could have a meal in honor of one of the countries playing that day. As Europeans like @FreddyLA7 discovered Waffle House, I wanted to discover my own country in a new way. At 17 meals down and 17 to go, a recap…
@JeffDooley_@kadiagoba@pkcapitol@deirdrekwalsh@NOTUSreports Also: @TomSietsema — one of the best food critics in the business — is joining NOTUS as a contributor with a weekly column answering reader questions. He was the first guest on The Friday Reporter in 2026. Full-circle moment and I am very excited about this.
The key point about China and biotech is being specific.
Manufacturing can be a physical choke point and supply diversity is important.
The same case for knowledge generation is harder.
But people with vested interests are exploiting an anti-China reflex to conflate the two.